Extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain)
Canadian Agency for Drugs and Technologies in Health
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Canadian Agency for Drugs and Technologies in Health. Extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain) Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Issues in Emerging Health Technologies Issue 96 Part 1. 2007
Authors' objectives
The aim of this bulletin is to provide an overview of extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain).
Authors' conclusions
The lack of convergent findings from randomized trials of ESWT for chronic plantar fasciitis suggests uncertainty about its effectiveness. The evidence reviewed in this bulletin does not support the use of this technology for this condition.